192 related articles for article (PubMed ID: 14604958)
1. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.
Ferrando AA; Herblot S; Palomero T; Hansen M; Hoang T; Fox EA; Look AT
Blood; 2004 Mar; 103(5):1909-11. PubMed ID: 14604958
[TBL] [Abstract][Full Text] [Related]
2. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.
Ferrando AA; Neuberg DS; Staunton J; Loh ML; Huard C; Raimondi SC; Behm FG; Pui CH; Downing JR; Gilliland DG; Lander ES; Golub TR; Look AT
Cancer Cell; 2002 Feb; 1(1):75-87. PubMed ID: 12086890
[TBL] [Abstract][Full Text] [Related]
3. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.
Ballerini P; Blaise A; Busson-Le Coniat M; Su XY; Zucman-Rossi J; Adam M; van den Akker J; Perot C; Pellegrino B; Landman-Parker J; Douay L; Berger R; Bernard OA
Blood; 2002 Aug; 100(3):991-7. PubMed ID: 12130513
[TBL] [Abstract][Full Text] [Related]
4. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
Ono Y; Fukuhara N; Yoshie O
J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
[TBL] [Abstract][Full Text] [Related]
6. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
7. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
[TBL] [Abstract][Full Text] [Related]
8. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
Ono Y; Fukuhara N; Yoshie O
Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
[TBL] [Abstract][Full Text] [Related]
9. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in T-cell acute lymphoblastic leukemia.
Ferrando AA; Look AT
Semin Hematol; 2003 Oct; 40(4):274-80. PubMed ID: 14582078
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
12. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
13. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.
Homminga I; Vuerhard MJ; Langerak AW; Buijs-Gladdines J; Pieters R; Meijerink JP
Haematologica; 2012 Feb; 97(2):258-61. PubMed ID: 22058201
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
[TBL] [Abstract][Full Text] [Related]
16. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
[TBL] [Abstract][Full Text] [Related]
17. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
[TBL] [Abstract][Full Text] [Related]
18. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
[TBL] [Abstract][Full Text] [Related]
19. SCL/TAL1: a multifaceted regulator from blood development to disease.
Porcher C; Chagraoui H; Kristiansen MS
Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
[TBL] [Abstract][Full Text] [Related]
20. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
